IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.42+0.17 (+5.23%)
Close on Nov 19, 2026Market cap $25.20MP/E –Yield –
Immutep free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -A$55.56M. The highest annual figure on record is -A$7.79M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$55.56M | – |
| FY2025 | Jun 30, 2025 | -A$62.10M | – |
| FY2024 | Jun 30, 2024 | -A$34.85M | – |
| FY2023 | Jun 30, 2023 | -A$35.44M | – |
| FY2022 | Jun 30, 2022 | -A$30.25M | – |
| FY2021 | Jun 30, 2021 | -A$17.66M | – |
| FY2020 | Jun 30, 2020 | -A$10.86M | – |
| FY2019 | Jun 30, 2019 | -A$15.33M | – |
| FY2018 | Jun 30, 2018 | -A$7.79M | – |
| FY2017 | Jun 30, 2017 | -A$8.51M | – |
| FY2016 | Jun 30, 2016 | -A$11.34M | – |
See a number that looks wrong?